Sympathetic vs Parasympathetic Nervous System: How to Tell Them Apart
The sympathetic and parasympathetic systems are the two arms of the autonomic nervous system, and both use a two-neuron relay in which the PREganglionic neuron releases acetylcholine onto nicotinic receptors in the ganglion. The axis that truly separates them is the POSTganglionic chemistry and the direction of the physiologic response: sympathetic postganglionic fibers generally release norepinephrine onto adrenergic receptors to drive 'fight or flight,' whereas parasympathetic postganglionic fibers release acetylcholine onto muscarinic receptors to mediate 'rest and digest.' Anchor on the effector-organ (postganglionic) neurotransmitter and receptor, plus the direction the target organ is moving.
How to tell them apart
| Feature | Sympathetic Nervous System | Parasympathetic Nervous System |
|---|---|---|
| Postganglionic (effector) neurotransmitter | Norepinephrine at most target organs — with classic exceptions: postganglionic sympathetic fibers to eccrine sweat glands release acetylcholine (acting on muscarinic receptors), and the adrenal medulla is driven directly by cholinergic preganglionic fibers, releasing epinephrine/NE into the blood | Acetylcholine at the effector organ |
| Effector-organ receptor (the distinguishing receptor) | Adrenergic receptors (α and β) | Muscarinic receptors |
| Anatomic outflow / origin | Thoracolumbar (T1–L2/L3) outflow with short preganglionic and long postganglionic fibers | Craniosacral outflow (CN III, VII, IX, X and S2–S4) with long preganglionic and short postganglionic fibers |
| Overall functional role | "Fight or flight" — mobilizes the body for stress and exertion | "Rest and digest" — conserves energy and supports recovery |
| Effect on heart rate | Increases heart rate and contractility (↑ HR) via β1 receptors | Slows the heart (↓ HR) via M2 receptors, consistent with the rest-and-digest state |
| Effect on blood pressure / systemic vasculature | Raises blood pressure by α1-mediated vasoconstriction of systemic vessels | Little direct effect — most systemic vasculature lacks parasympathetic innervation, so any BP change is indirect (via reduced heart rate/contractility) |
| Effect on the airways | Bronchodilation (β2) to increase airflow | Bronchoconstriction (M3), part of the resting profile |
| Effect on the pupil | Mydriasis (pupillary dilation) via α1 on the radial muscle | Miosis (pupillary constriction) via M3 on the sphincter muscle |
The reasoning
Start with two anchors at the effector organ. First, the postganglionic neurotransmitter: norepinephrine points to the sympathetic system and acetylcholine to the parasympathetic — while remembering that ganglionic transmission is cholinergic (nicotinic) in BOTH systems, so nicotinic signaling cannot arbitrate. Second, the effector-organ receptor: adrenergic (α, β) is sympathetic, muscarinic is parasympathetic. When chemistry is ambiguous, arbitrate on the direction of the physiologic response — the sympathetic system produces increased heart rate, α1-mediated vasoconstriction with higher blood pressure, bronchodilation, and mydriasis, whereas the parasympathetic system produces the opposing rest-and-digest pattern. Because these systems act on shared organs in opposite directions, always define which direction the effector is moving, and keep the cholinergic sympathetic exceptions (sweat glands, adrenal medulla) in mind.
Key tests
- Identification of the postganglionic (effector) neurotransmitter: norepinephrine indicates sympathetic signaling, acetylcholine indicates parasympathetic signaling — but recall the cholinergic sympathetic exceptions (sweat glands, adrenal medulla)
- Effector-organ receptor pharmacology: an adrenergic (α/β) response marks sympathetic activity, whereas a muscarinic response marks parasympathetic activity; a nicotinic (ganglionic) response does NOT distinguish the two because it is present in both
- Physiologic response pattern: rising heart rate, α1-mediated rise in blood pressure, bronchodilation, and mydriasis signal sympathetic ('fight or flight') activation, whereas bradycardia, bronchoconstriction, miosis, and increased GI activity signal parasympathetic dominance
What they share
- Both are divisions of the autonomic nervous system that regulate involuntary visceral function
- Both operate through a two-neuron pathway with a ganglionic relay before reaching target organs
- In both systems the preganglionic neuron is cholinergic and acts on nicotinic acetylcholine receptors in the ganglion — nicotinic transmission is common to both and is NOT a distinguishing feature
- Both act on many of the same core organs (heart, airways, GI tract, pupil) but push them in opposite directions
Pitfalls
- Treating nicotinic receptors as a parasympathetic feature — nicotinic receptors mediate ganglionic transmission in BOTH sympathetic and parasympathetic divisions (and at the adrenal medulla and neuromuscular junction); only muscarinic receptors at the effector organ are distinctly parasympathetic
- Assuming all sympathetic postganglionic fibers are noradrenergic — eccrine sweat glands are innervated by cholinergic sympathetic fibers (acting on muscarinic receptors), and the adrenal medulla is a modified ganglion driven by cholinergic preganglionic fibers
- Claiming the parasympathetic system actively 'lowers blood pressure' — most systemic arterioles have no parasympathetic supply, so blood pressure falls only indirectly through reduced heart rate and contractility
- Forgetting that both systems target the same organs; the diagnostic point is the direction of the effect (bronchodilation vs bronchoconstriction, faster vs slower heart rate, mydriasis vs miosis), not merely which organ is involved
- Equating 'sympathetic' only with the heart — its 'fight-or-flight' profile spans heart rate, vascular tone/blood pressure, airway caliber, and pupil size simultaneously
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.